A double‐blind randomized dose‐response study comparing daily doses of 5, 10 and 15 mg controlled‐release oxybutynin: balancing efficacy with severity of dry mouth

OBJECTIVE To assess the efficacy, incidence of dry mouth and overall satisfaction with initial doses of 5, 10 and 15 mg of a new, once‐daily, controlled‐release (CR) form of oxybutynin for treating urge urinary incontinence (UUI). PATIENTS AND METHODS Patients who reported urinary incontinence (UI)...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BJU international 2006-03, Vol.97 (3), p.520-527
Hauptverfasser:	CORCOS, JAQUES, CASEY, RICHARD, PATRICK, ALLAN, ANDREOU, CAL, MICELI, PAULA C., REIZ, JOSEPH L., HARSANYI, ZOLTAN, DARKE, ANDREW C.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences bladder cholinergic antagonist Delayed-Action Preparations - administration & dosage Delayed-Action Preparations - adverse effects Dose-Response Relationship, Drug Double-Blind Method drug delivery systems Female Humans Male Mandelic Acids - administration & dosage Mandelic Acids - adverse effects Medical sciences Middle Aged Nephrology. Urinary tract diseases Patient Satisfaction pharmacology Pharmacology. Drug treatments Severity of Illness Index Treatment Outcome urinary incontinence Urinary Incontinence - drug therapy Urinary system Urinary system involvement in other diseases. Miscellaneous Urinary tract. Prostate gland Xerostomia - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!